MUC16 and pancreatic neoplasm: Interestingly, these alterations also occur in pancreatic cancer, where they have been associated with disease progression and metastasis through the activation of oncogenic pathways via the interaction between aberrant MUC16 isoforms and epidermal growth factor (EGF) receptors [72].